For more than 50 years, SRI Biosciences has worked with academic, commercial, foundation, and government clients and partners to bring new medicines to market through basic research, pharmaceutical discovery, preclinical development, and clinical translation.
Today, combining the approaches of a nonprofit research institute, a biotech venture, and a contract research organization (CRO), SRI Biosciences integrates all of the R&D resources necessary to take drugs from Idea to IND®—from initial discoveries to investigational new drug applications. SRI uses biosciences technology to understand disease mechanisms, identify promising leads, and translate preclinical candidates into clinical development.
In its capacity as a full-service CRO, SRI Biosciences has worked with clients to conduct bioscience research, and advance more than 100 drugs to human trials, and SRI’s own pipeline has yielded several marketed products. Core areas of therapeutic expertise include cancer, immunology and inflammation, infectious disease, and neuroscience. SRI also conducts bioscience research and development to produce new biomarkers, drug delivery technologies, medical devices, and systems biology tools. SRI serves as a complete and reliable source for services ranging ™, including chemical synthesis, screening, efficacy, formulation, pharmacokinetics, safety, and regulatory support.
SRI Biosciences helps to solve important problems in prevention, diagnosis, and treatment, targeting important unmet needs in healthcare, and saving and improving lives worldwide. SRI offers passionate champions, multidisciplinary teams, rigorous science, a commitment to excellence, and strict adherence to regulatory guidelines. Applying the SRI Five Disciplines of Innovation®, our staff adds value seamlessly, with diverse biomedical capabilities and state-of-the-art facilities.
The only full-service CRO based on the West Coast, SRI Biosciences works with large and small pharmaceutical and biotechnology clients, including global pharmaceutical companies and start-up biotechnology ventures. SRI Shenandoah Valley, a state-of-the-art 40,000-square-foot research facility in Harrisonburg, Virginia, provides a convenient base for collaboration with academic institutions in Virginia and the greater Washington, D.C. area.